EP1001964A4 - Tango-78, tango-79 und tango-81 nukleinsäuremoleküle und polypeptide - Google Patents

Tango-78, tango-79 und tango-81 nukleinsäuremoleküle und polypeptide

Info

Publication number
EP1001964A4
EP1001964A4 EP98939212A EP98939212A EP1001964A4 EP 1001964 A4 EP1001964 A4 EP 1001964A4 EP 98939212 A EP98939212 A EP 98939212A EP 98939212 A EP98939212 A EP 98939212A EP 1001964 A4 EP1001964 A4 EP 1001964A4
Authority
EP
European Patent Office
Prior art keywords
tango
polypeptides
nucleic acid
acid molecules
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP98939212A
Other languages
English (en)
French (fr)
Other versions
EP1001964A1 (de
Inventor
Sean A Mccarthy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of EP1001964A1 publication Critical patent/EP1001964A1/de
Publication of EP1001964A4 publication Critical patent/EP1001964A4/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP98939212A 1997-08-04 1998-08-04 Tango-78, tango-79 und tango-81 nukleinsäuremoleküle und polypeptide Ceased EP1001964A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5464597P 1997-08-04 1997-08-04
US54645P 1997-08-04
PCT/US1998/016241 WO1999006427A1 (en) 1997-08-04 1998-08-04 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides

Publications (2)

Publication Number Publication Date
EP1001964A1 EP1001964A1 (de) 2000-05-24
EP1001964A4 true EP1001964A4 (de) 2003-04-23

Family

ID=21992541

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98939212A Ceased EP1001964A4 (de) 1997-08-04 1998-08-04 Tango-78, tango-79 und tango-81 nukleinsäuremoleküle und polypeptide

Country Status (5)

Country Link
EP (1) EP1001964A4 (de)
JP (1) JP2001512003A (de)
AU (1) AU8768798A (de)
CA (1) CA2299276A1 (de)
WO (1) WO1999006427A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000066778A1 (en) * 1999-04-30 2000-11-09 Human Genome Sciences, Inc. Pituitrone gene and polypeptides
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2399652A1 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Methods and materials relating to neuronal guidance molecule-like (ngm-like) polypeptides and polynucleotides
JP2003523190A (ja) * 2000-02-14 2003-08-05 スミスクライン・ビーチャム・コーポレイション 新規化合物
WO2002016579A2 (en) * 2000-08-24 2002-02-28 Eli Lilly And Company Nucleic acids, vectors, host cells, polypeptides and uses thereof
US6482936B1 (en) * 2001-04-17 2002-11-19 Pe Corporation (Ny) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
US7223558B2 (en) * 2001-07-11 2007-05-29 Bristol-Myers Squibb Company Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereof
RS54160B1 (sr) 2003-03-19 2015-12-31 Biogen Idec Ma Inc. Protein koji se vezuje za nogo receptor
KR101239542B1 (ko) 2004-06-24 2013-03-07 바이오겐 아이덱 엠에이 인코포레이티드 탈수초화를 수반하는 병의 치료
RS53058B (en) 2005-07-08 2014-04-30 Biogen Idec Ma Inc. SP35 ANTIBODIES AND THEIR APPLICATIONS
US8128926B2 (en) 2007-01-09 2012-03-06 Biogen Idec Ma Inc. Sp35 antibodies and uses thereof
DK2982695T3 (da) 2008-07-09 2019-05-13 Biogen Ma Inc Sammensætninger, der omfatter antistoffer mod lingo eller fragmenter deraf
NZ702178A (en) 2012-05-14 2017-01-27 Biogen Ma Inc Lingo-2 antagonists for treatment of conditions involving motor neurons
AU2016205197B2 (en) 2015-01-08 2021-10-21 Biogen Ma Inc. LINGO-1 antagonists and uses for treatment of demyelinating disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998012322A1 (en) * 1996-09-18 1998-03-26 Genetics Institute, Inc. Bone morphogenetic protein-16 (bmp-16) compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998012322A1 (en) * 1996-09-18 1998-03-26 Genetics Institute, Inc. Bone morphogenetic protein-16 (bmp-16) compositions

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 17 February 1995 (1995-02-17), AUFFRAY ET AL., XP002230668, retrieved from EBI Database accession no. F08555 *
DATABASE EMBL [online] 6 March 1997 (1997-03-06), HILLIER ET AL., XP002230667, retrieved from EBI Database accession no. AA233924 *
See also references of WO9906427A1 *
SUZUKI Y ET AL: "cDNA cloning of a novel membrane glycoprotein that is expresed specifically in glial cells in the mouse brain", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 271, no. 37, 13 September 1996 (1996-09-13), pages 22522 - 22527, XP002119249, ISSN: 0021-9258 *
ZHOU X ET AL: "NODAL IS A NOVEL TGF-BETA-LIKE GENE EXPRESSED IN THE MOUSE NODE DURING GASTRULATION", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 361, 11 February 1993 (1993-02-11), pages 543 - 547, XP002047505, ISSN: 0028-0836 *

Also Published As

Publication number Publication date
AU8768798A (en) 1999-02-22
WO1999006427A1 (en) 1999-02-11
CA2299276A1 (en) 1999-02-11
JP2001512003A (ja) 2001-08-21
EP1001964A1 (de) 2000-05-24

Similar Documents

Publication Publication Date Title
AU4567499A (en) Novel mtbx protein and nucleic acid molecules and uses therefor
HUP0001930A3 (en) Modified tnfalpha molecules, dna encoding such modified tnfalpha molecules and vaccines comprising such modified tnfalpha molecules and dna
IL135823A0 (en) Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
EP1001964A4 (de) Tango-78, tango-79 und tango-81 nukleinsäuremoleküle und polypeptide
IL136696A0 (en) Sigirr dna and polypeptides
IL132465A0 (en) Characterising dna
ZA9710163B (en) Novel carboxylesterase nucleic acid molecules, proteins and uses thereof.
HUP0104825A3 (en) Genes and proteins, and their use
IL138216A0 (en) Novel fdrg protein and nucleic acid molecules and uses therefor
AU5901199A (en) Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
AU5800996A (en) Nes-1 polypeptides, dna, and related molecules and methods
EP1071749A4 (de) Neues lrsg-protein und nukleinsäuremoleküle sowie deren verwendung
IL137493A0 (en) Svph3-13 and spvh3-17 dna and polypeptides
IL136988A0 (en) Novel nucleic acid and polypeptide
IL136695A0 (en) V201 dna and polypeptides
EP1012160A4 (de) Tango-72 und tango-77 nukleinsäuremoleküle und polypeptide
EP1007682A4 (de) Neuartige nukleinsäuremoleküle und deren verwendungen
EP1142999A4 (de) Protein und dessen dns
GB9726575D0 (en) Nucleic acid, polypeptides, assays, therapeutic methods and means
AU2059500A (en) Huhdgfh nucleic acids, polypeptides, methods and uses thereof
EP1066310A4 (de) Neokin-proteine und nukleinsäuren und ihre anwendung
AU5312699A (en) Novel mp-7 protein and nucleic acid molecules and uses therefor
AU4826899A (en) Novel msp-5 protein and nucleic acid molecules and uses therefor
IL135855A0 (en) Svphi-26 nucleic acids, polypeptides and methods for producing the same
IL136693A0 (en) V196 dna and polypeptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000303

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MILLENNIUM PHARMACEUTICALS, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20030307

17Q First examination report despatched

Effective date: 20030725

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20060510